GLP-1 agonists have been clinically proven to support sustained weight loss and improve overall health for people struggling with their weight
Frandsen CS, Dejgaard TF, Holst JJ, Andersen HU, Thorsteinsson B, Madsbad S
For example, it is used alongside peptides, antioxidants, and delivery technologies to create high-performance formulations
Have you been eating well, exercising consistently, and still struggling with stubborn weight, low energy, or poor sleep
Indias GLP-1 market is set for a major shift as MANKIND PHARMA LTD targets an early launch of semaglutide following the expected patent expiry in March 2026